| Grant |
hpEpt1 IN INTESTINAL INFLAMMATION |
$54,403 |
Atlanta |
GA |
0 |
0 |
| Grant |
PREDOCTORAL TRAINING PROGRAM IN GENETICS |
$174,056 |
Atlanta |
GA |
0 |
0 |
| Grant |
EFFICACY AND MECHANISM OF GLN DEPEPTIDE IN THE SICU |
$150,000 |
Atlanta |
GA |
0 |
0 |
| Grant |
NEUROBIOLOGICAL CIRCUITS OF GAIN AND LOSS DURING RISKY DECISION MAKING |
$476,196 |
Atlanta |
GA |
2 |
1 |
| Grant |
THE PATHOGENESIS OF SICKLE CELL NEPHROPATHY |
$350,001 |
Atlanta |
GA |
2 |
1 |
| Grant |
ROLE OF SYK AND RAC2 IN THE REGULATION OF HIF1A AND NEOVASCULARIZATION |
$193,750 |
Atlanta |
GA |
3 |
0 |
| Grant |
ADAPTATION OF COUPLES VOLUNTARY COUNSELING AND TESTING (CVCT) FOR US MSM |
$357,170 |
Atlanta |
GA |
0 |
0 |
| Grant |
SUPPORT OF YERKES NATIONAL PRIMATE RESEARCH CENTER |
$192,292 |
Atlanta |
GA |
11 |
0 |
| Grant |
A C.ELEGANS MODEL FOR EPEC AND EHEC PATHOGENESIS |
$99,984 |
Atlanta |
GA |
0 |
0 |
| Grant |
NOX4 AND CARDIAC FIBROSIS |
$273,118 |
Atlanta |
GA |
0 |
0 |
| Grant |
EMORY EPITHELIAL PATHOBIOLOGY RESEARCH DEVELOPMENT CENTER |
$99,901 |
Atlanta |
GA |
0 |
0 |
| Grant |
DEVELOPMENT OF TRANSPLANT STRATEGIES UNIQUELY RESPONSIVE TO THE NEEDS OF CHILDREN |
$1,649,526 |
Atlanta |
GA |
0 |
0 |
| Grant |
PERCEPTION OF OBJECT MOTION FROM OPTICAL, BINOCULAR AND SCENE INFORMATION |
$144,810 |
Riverside |
CA |
0 |
1 |
| Grant |
HCO3- CONDUCTIVE FUNCTION OF CFTR: IMPLICATIONS TO ORAL HEALTH & CYSTIC FIBROSIS |
$463,500 |
La Jolla |
CA |
3 |
-1 |
| Grant |
HIV-INDUCED 5-LIPOXYGENASE: ROLE IN HIV-RELATED PULMONARY ATERIAL HYPERTENSION |
$29,124 |
Atlanta |
GA |
0 |
0 |
| Grant |
DESIGN OF NEW TREATMENT AGENTS FOR DRUG ABUSE |
$393,200 |
Atlanta |
GA |
0 |
1 |
| Grant |
EMORY-GEORGIA TB RESEARCH TRAINING PROGRAM |
$172,186 |
Atlanta |
GA |
0 |
-1 |
| Grant |
PROLIFERATIVE RESPONSES TO ENTERIC PATHOGENS IN INTESTINAL TISSUES |
$54,000 |
Atlanta |
GA |
0 |
0 |
| Grant |
REGULATION OF RAT RENAL INNER MEDULLARY FUNCTION |
$100,000 |
Atlanta |
GA |
0 |
0 |
| Grant |
BCR1P AS A CANDIDA NEUTROPHIL RESISTANCE REGULATOR |
$70,460 |
Torrance |
CA |
0 |
0 |
